Embecta Corp (EMBC) - Total Assets
Based on the latest financial reports, Embecta Corp (EMBC) holds total assets worth $1.06 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See EMBC total equity for net asset value and shareholders' equity analysis.
Embecta Corp - Total Assets Trend (2019–2025)
This chart illustrates how Embecta Corp's total assets have evolved over time, based on quarterly financial data.
Embecta Corp - Asset Composition Analysis
Current Asset Composition (September 2025)
Embecta Corp's total assets of $1.06 Billion consist of 57.9% current assets and 42.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 20.7% |
| Accounts Receivable | $148.90 Million | 13.7% |
| Inventory | $178.60 Million | 16.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $7.00 Million | 0.6% |
| Goodwill | $15.40 Million | 1.4% |
Asset Composition Trend (2019–2025)
This chart illustrates how Embecta Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Embecta Corp.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Embecta Corp's current assets represent 57.9% of total assets in 2025, an increase from 33.3% in 2019.
- Cash Position: Cash and equivalents constituted 20.7% of total assets in 2025, up from 0.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 4.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 16.4% of total assets.
Embecta Corp Competitors by Total Assets
Key competitors of Embecta Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Alcon AG
SW:ALC
|
Switzerland | CHF31.53 Billion |
|
iRay Technology Co Ltd
SHG:688301
|
China | CN¥11.33 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
|
USA | $32.49 Million |
|
Jiangsu Nanfang Medical
SHG:603880
|
China | CN¥993.46 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
Embecta Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.64 | 2.24 | 1.78 |
| Quick Ratio | 1.87 | 1.67 | 1.06 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $385.50 Million | $369.00 Million | $128.00 Million |
Embecta Corp - Advanced Valuation Insights
This section examines the relationship between Embecta Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.61 |
| Latest Market Cap to Assets Ratio | 0.50 |
| Asset Growth Rate (YoY) | -15.1% |
| Total Assets | $1.09 Billion |
| Market Capitalization | $546.60 Million USD |
Valuation Analysis
Below Book Valuation: The market values Embecta Corp's assets below their book value (0.50x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Embecta Corp's assets decreased by 15.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Embecta Corp (2019–2025)
The table below shows the annual total assets of Embecta Corp from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $1.09 Billion | -15.12% |
| 2024-09-30 | $1.29 Billion | +5.84% |
| 2023-09-30 | $1.21 Billion | +11.78% |
| 2022-09-30 | $1.09 Billion | +37.87% |
| 2021-09-30 | $788.00 Million | +6.78% |
| 2020-09-30 | $738.00 Million | -0.94% |
| 2019-09-30 | $745.00 Million | -- |
About Embecta Corp
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors… Read more